Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX2 | P34913 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.34 |
| ▸ | USP2 | O75604 | 1/20 | 0.34 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.34 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.32 |
| ▸ | SMYD3 | Q9H7B4 | 1/20 | 0.32 |
| ▸ | KLK7 | P49862 | 1/20 | 0.31 |
| ▸ | PPM1B | O75688 | 1/20 | 0.30 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.30 |
| ▸ | PPP1CC | P36873 | 1/20 | 0.30 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
| ▸ | ATM | Q13315 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14864455 | 0.87 | EPHX2 (0.43) | EPHX2ALDH1A1TDP1USP2ALOX15 | |
| SCHEMBL4569186 | 0.81 | MAPT (0.43) | EPHX2ALDH1A1TDP1USP2ALOX15 | |
| SCHEMBL10073831 | 0.80 | ALDH1A1 (0.46) | EPHX2ALDH1A1TDP1USP2ALOX15 | |
| SCHEMBL12284783 | 0.77 | ALDH1A1 (0.43) | ALDH1A1TDP1USP2ALOX15L3MBTL1 | |
| SCHEMBL3476775 | 0.75 | ALDH1A1 (0.43) | EPHX2ALDH1A1TDP1USP2ALOX15 | |
| SCHEMBL18623243 | 0.75 | ALDH1A1 (0.50) | ALDH1A1TDP1USP2ALOX15HPGD | |
| SCHEMBL3912258 | 0.72 | ALDH1A1 (0.42) | EPHX2ALDH1A1TDP1USP2ALOX15 | |
| SCHEMBL11953521 | 0.72 | ALDH1A1 (0.45) | ALDH1A1TDP1USP2ALOX15HPGD | |
| SCHEMBL19853866 | 0.72 | ALDH1A1 (0.47) | EPHX2ALDH1A1TDP1USP2ALOX15 | |
| SCHEMBL3477288 | 0.71 | ALDH1A1 (0.40) | EPHX2ALDH1A1TDP1USP2ALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120123074-A1 | DI(METH)ACRYLATE COMPOUND, POLYMERIZABLE LIQUID CRYSTAL COMPOSITION, OPTICAL ANISOTROPIC MATERIAL, OPTICAL ELEMENT AND OPTICAL INFORMATION WRITING/READING DEVICE | ASAHI GLASS COMPANY, LIMITED (JP) | 2012-05-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120123074-A1 | DI(METH)ACRYLATE COMPOUND, POLYMERIZABLE LIQUID CRYSTAL COMPOSITION, OPTICAL ANISOTROPIC MATERIAL, OPTICAL ELEMENT AND OPTICAL INFORMATION WRITING/READING DEVICE | METTL3, METTL14, METTL16 | EPHX2 3872/4885ALDH1A1 1361/4885TDP1 1074/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.